You need to enable JavaScript to run this app.
FDA issues final guidance on CMC postapproval changes for biologics
Regulatory News
Biologics
Chemistry, Manufacturing and Controls (CMC)
Compliance
North America
Quality Assurance and Control
Regulatory Intelligence/Policy